128 related articles for article (PubMed ID: 34001380)
1. The Impact of Intra-thoracic Anatomical Changes upon the Delivery of Lung Stereotactic Ablative Radiotherapy.
Brown S; Beasley M; Aznar MC; Belderbos J; Chuter R; Cobben D; Faivre-Finn C; Franks K; Henry A; Murray L; Price G; van Herk M
Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):e413-e421. PubMed ID: 34001380
[TBL] [Abstract][Full Text] [Related]
2. Intra thoracic anatomical changes in lung cancer patients during the course of radiotherapy.
Kwint M; Conijn S; Schaake E; Knegjens J; Rossi M; Remeijer P; Sonke JJ; Belderbos J
Radiother Oncol; 2014 Dec; 113(3):392-7. PubMed ID: 25467051
[TBL] [Abstract][Full Text] [Related]
3. Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforce.
Edwards JP; Datta I; Hunt JD; Stefan K; Ball CG; Dixon E; Grondin SC
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1599-606. PubMed ID: 26796110
[TBL] [Abstract][Full Text] [Related]
4. Variations of target volume definition and daily target volume localization in stereotactic body radiotherapy for early-stage non-small cell lung cancer patients under abdominal compression.
Han C; Sampath S; Schultheisss TE; Wong JYC
Med Dosim; 2017 Summer; 42(2):116-121. PubMed ID: 28433482
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.
Sun Y; Ge H; Cheng S; Yang C; Zhu Q; Li D; Tian Y
J Appl Clin Med Phys; 2016 Mar; 17(2):461-472. PubMed ID: 27074466
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Ablative Radiation Therapy for Large (≥5 cm) Non-small Cell Lung Carcinoma.
McDermott RL; Mihai A; Dunne M; Keys M; O'Sullivan S; Thirion P; ElBeltagi N; Armstrong JG
Clin Oncol (R Coll Radiol); 2021 May; 33(5):292-299. PubMed ID: 33309479
[TBL] [Abstract][Full Text] [Related]
7. Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy.
Tekatli H; Palacios MA; Schneiders FL; Haasbeek CJA; Slotman BJ; Lagerwaard FJ; Senan S
Radiother Oncol; 2023 Oct; 187():109823. PubMed ID: 37516364
[TBL] [Abstract][Full Text] [Related]
8. MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose.
Booth J; Caillet V; Briggs A; Hardcastle N; Angelis G; Jayamanne D; Shepherd M; Podreka A; Szymura K; Nguyen DT; Poulsen P; O'Brien R; Harris B; Haddad C; Eade T; Keall P
Radiother Oncol; 2021 Feb; 155():131-137. PubMed ID: 33152399
[TBL] [Abstract][Full Text] [Related]
9. Long-term Overall Survival Outcomes in Patients with Early Stage, Peripherally Located, Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy in a Non-academic Cancer Centre.
Wood A; Aynsley E; Kumar G; Masinghe S; Anderson M; Veeratterapillay J; Huntley C; Blower A; Green J; Johnson D; Daniel J; Curtis H; Reynolds J; Turnbull M; Harland K; Swingler A; Banham E; Burke K; Bradley J; Greenhalgh A; Peedell C
Clin Oncol (R Coll Radiol); 2021 May; 33(5):283-291. PubMed ID: 33341333
[TBL] [Abstract][Full Text] [Related]
10. Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy.
Li R; Han B; Meng B; Maxim PG; Xing L; Koong AC; Diehn M; Loo BW
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):917-23. PubMed ID: 24113060
[TBL] [Abstract][Full Text] [Related]
11. An assessment of cone beam CT in the adaptive radiotherapy planning process for non-small-cell lung cancer patients.
Duffton A; Harrow S; Lamb C; McJury M
Br J Radiol; 2016 Jun; 89(1062):20150492. PubMed ID: 27052681
[TBL] [Abstract][Full Text] [Related]
12. Gross tumour volume variations in primary non-small-cell lung cancer during the course of treatment with stereotactic body radiation therapy.
Gunter T; Ali I; Matthiesen C; Machiorlatti M; Thompson D; Algan O
J Med Imaging Radiat Oncol; 2014; 58(3):384-91. PubMed ID: 24592817
[TBL] [Abstract][Full Text] [Related]
13. Can dosimetry affect local control and survival in patients with early-stage lung cancer treated with Stereotactic Ablative Radiotherapy (SABR)? An analysis of the UK's largest cohort of lung SABR patients.
Saha A; Beasley M; Hatton N; Dickinson P; Franks K; Clarke K; Jain P; Teo M; Murray P; Lilley J
Acta Oncol; 2021 Apr; 60(4):505-512. PubMed ID: 33491521
[TBL] [Abstract][Full Text] [Related]
14. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
[TBL] [Abstract][Full Text] [Related]
15. Contact of a tumour with the pleura is not associated with regional recurrence following stereotactic ablative radiotherapy for early stage non-small cell lung cancer.
Wink KCJ; Löck S; Rossi M; van Baardwijk A; Belderbos J; de Ruysscher D; Troost EGC
Radiother Oncol; 2019 Feb; 131():120-126. PubMed ID: 30773178
[TBL] [Abstract][Full Text] [Related]
16. Application of real-time MRI-guided linear accelerator in stereotactic ablative body radiotherapy for non-small cell lung cancer: one step forward to precise targeting.
Kang HJ; Kwak YK; Kim M; Lee SJ
J Cancer Res Clin Oncol; 2022 Nov; 148(11):3215-3223. PubMed ID: 36040666
[TBL] [Abstract][Full Text] [Related]
17. Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).
Palma DA; Nguyen TK; Kwan K; Gaede S; Landis M; Malthaner R; Fortin D; Louie AV; Frechette E; Rodrigues GB; Yaremko B; Yu E; Dar AR; Lee TY; Gratton A; Warner A; Ward A; Inculet R
Radiat Oncol; 2017 Jan; 12(1):30. PubMed ID: 28129789
[TBL] [Abstract][Full Text] [Related]
18. Late Toxicity and Long-Term Local Control in Patients With Ultra-Central Lung Tumours Treated by Intensity-Modulated Radiotherapy-Based Stereotactic Ablative Body Radiotherapy With Homogenous Dose Prescription.
Mihai AM; Armstrong PJ; Hickey D; Milano MT; Dunne M; Healy K; Thirion P; Heron DE; ElBeltagi N; Armstrong JG
Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):627-637. PubMed ID: 34092462
[TBL] [Abstract][Full Text] [Related]
19. Clinical validation of a semi-automated segmentation algorithm for target volume definition on planning CT and CBCT in stereotactic body radiotherapy (SBRT) for peripheral lung lesions.
Mohamed AA; Risse K; Schmitz L; Schlenter M; Chughtai A; Ivanciu M; Eble MJ
J Med Radiat Sci; 2023 Apr; 70 Suppl 2(Suppl 2):37-47. PubMed ID: 36424343
[TBL] [Abstract][Full Text] [Related]
20. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
